|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | G01N 33/574 | (2006.01) |
| (11) | Number of the document | 4526683 |
| (13) | Kind of document | T |
| (96) | European patent application number | 23726545.9 |
| Date of filing the European patent application | 2023-05-19 | |
| (97) | Date of publication of the European application | 2025-03-26 |
| (45) | Date of publication and mention of the grant of the patent | 2025-12-03 |
| (46) | Date of publication of the claims translation | 2026-03-10 |
| (86) | Number | PCT/FI2023/050280 |
| Date | 2023-05-19 |
| (87) | Number | WO 2023/222953 |
| Date | 2023-11-23 |
| (30) | Number | Date | Country code |
| 20225445 | 2022-05-20 | FI | |
| 20225962 | 2022-10-26 | FI |
| (72) |
JALKANEN, Juho , FI
BJÖRKMAN, Mari , FI
HOLLMÉN, Maija-Leena , FI
|
| (73) |
Faron Pharmaceuticals OY ,
Joukahaisenkatu 6, 20520 Turku,
FI
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Vėžiu sergančių pacientų, tinkamų gydymui anti-CLEVER-1, identifikavimo būdas |
| METHOD FOR IDENTIFYING CANCER PATIENTS THAT BENEFIT FROM ANTI-CLEVER-1 TREATMENT |